Cargando…
Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi that endangers almost 70 million people worldwide. The only two drugs that are currently approved for its treatment, benznidazole and nifurtimox, have controversial efficacy in adults and restricting sa...
Autores principales: | de Oliveira, Ramon G., Cruz, Luiza R., Mollo, María C., Dias, Luiz C., Kratz, Jadel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581468/ https://www.ncbi.nlm.nih.gov/pubmed/34778217 http://dx.doi.org/10.3389/fchem.2021.771143 |
Ejemplares similares
-
Has the prevalence of Chagas disease increased in Central Latin America?
por: Yoshioka, Kota, et al.
Publicado: (2020) -
The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America
por: Picado, Albert, et al.
Publicado: (2018) -
The translational challenge in Chagas disease drug development
por: Kratz, Jadel M, et al.
Publicado: (2022) -
Chagas disease: an impediment in achieving the Millennium Development Goals in Latin America
por: Franco-Paredes, Carlos, et al.
Publicado: (2007) -
Cancer mortality predictions for 2021 in Latin America
por: Carioli, Greta, et al.
Publicado: (2021)